Pharma News FDA approves pirtobrutinib for the treatment of advanced relapsed/refractory mantle cell lymph... Read more
Pharma News FDA accepts license application of reformulated denileukin diftitox for patients with CTCL Read more
Pharma News Zanubrutinib as a new treatment option for patients with Waldenström macroglobulinaemia Read more
Pharma News FDA approval for brentuximab vedotin for children with high-risk Hodgkin lymphoma Read more
Pharma News FDA’s decision on gene therapy Roctavian for adults with haemophilia A in early 2023 Read more
Pharma News Axicabtagene ciloleucel receives European nod as second-line treatment for large B-cell lympho... Read more
